Perspective Therapeutics, Inc. (CATX) Balance Sheet
As of 2026-06-30 (10-Q), Perspective Therapeutics, Inc. (CATX) reported total assets of $392.0M, total liabilities of $68.2M and shareholders' equity of $323.9M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $48.5M. Long-term debt: $1.5M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CATXPerspective Therapeutics, Inc.Follow CATX — free
—
Price chart with a free account
- Market cap
- 183.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
| Line | FY2012 Jun 12 | FY2013 Jun 13 | FY2014 Jun 14 | FY2015 Jun 15 | FY2016 Jun 16 | FY2017 Jun 17 | FY2018 Jun 18 | FY2019 Jun 19 | FY2020 Jun 20 | FY2021 Jun 21 | FY2022 Jun 22 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 2.7 | 2.9 | 7.7 | 5.2 | 10.1 | 5.9 | 2.6 | 5.3 | 2.4 | 63.8 | 55.9 | 21.0 | 9.2 | 61.6 | 30.6 | 48.5 | |
| Short-term investments | — | — | 10.0 | 9.4 | 2.2 | 3.0 | 0.8 | — | — | 0.0 | 0.0 | 22.8 | 0.0 | 165.3 | 114.1 | 188.4 | |
| Receivables | 0.9 | 0.9 | 0.9 | 1.0 | 0.6 | 0.7 | 1.2 | 1.2 | 2.0 | 2.0 | 1.6 | 1.4 | 1.2 | 0.1 | 0.0 | 0.3 | |
| Inventory | 0.4 | 0.4 | 0.4 | 0.4 | 0.3 | 0.3 | 0.5 | 0.5 | 0.6 | 1.0 | 1.4 | 1.4 | — | — | — | — | |
| Current assets | 4.1 | 4.4 | 19.2 | 16.3 | 13.6 | 10.3 | 5.4 | 7.3 | 5.5 | 67.3 | 59.3 | 53.2 | 16.8 | 231.2 | 148.4 | 241.5 | |
| Total assets | 7.5 | 7.1 | 26.5 | 23.0 | 18.1 | 12.3 | 7.5 | 9.4 | 8.7 | 70.4 | 64.4 | 58.1 | 97.9 | 341.1 | 267.0 | 392.0 | |
| Current liabilities | 0.6 | 0.8 | 1.2 | 1.1 | 1.1 | 1.1 | 1.8 | 1.1 | 1.6 | 1.8 | 2.3 | 3.1 | 15.7 | 18.2 | 28.7 | 36.5 | |
| Long-term debt | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 1.7 | 1.6 | 1.6 | 1.5 | |
| Total liabilities | 1.7 | 1.7 | 2.6 | 2.2 | 1.7 | 1.7 | 2.4 | 1.7 | 3.0 | 3.0 | 3.2 | 3.4 | 22.7 | 50.4 | 59.9 | 68.2 | |
| Shareholders' equity | 5.8 | 5.4 | 24.0 | 20.8 | 16.4 | 10.6 | 5.0 | 7.7 | 5.7 | 67.4 | 61.3 | 54.6 | 75.2 | 290.7 | 207.0 | 323.9 |
USD millions · SEC XBRL
Perspective Therapeutics, Inc. — questions
- How much cash does Perspective Therapeutics, Inc. have?
- $48.5M in cash and cash equivalents as of 2026-06-30.
- How much debt does Perspective Therapeutics, Inc. have?
- $1.5M of long-term debt as of 2026-06-30.
- What are Perspective Therapeutics, Inc.'s total assets?
- $392.0M as of 2026-06-30.
- What is Perspective Therapeutics, Inc.'s shareholders' equity?
- $323.9M as of 2026-06-30.
Every figure on this page comes from Perspective Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.